公司资料
Corbus Pharmaceuticals 股价、新闻与催化剂
- 股票代码:
- CRBP
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
2.86 USD (-19.89%)
收盘价
最后更新: 2026年11月5日
140M USD
市值
股价为何变动
截至 2026年11月5日，CRBP 下跌 19.9%，收于 $2.86。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
业务概览
Corbus Pharmaceuticals is a biotechnology company focused on inflammation, oncology, and endocannabinoid biology. Its story is built around a narrow set of clinical programs and strategic repositioning.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Corbus sits in specialty biotechnology.
商业模式特征
The company depends on clinical data, target selection, and the ability to create a differentiated pipeline in immune disease and cancer.
生物医药行业定位
Corbus is a small-cap catalyst name whose valuation is heavily dependent on program progress.
未来催化剂
- Corbus’s catalysts are CRB-701 and CRB-913, with oncology and obesity updates doing most of the work. The company will be judged on whether its next data can support a larger development step.
近期新闻
新闻标题由机器翻译，详情为英文原文。
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。